US Supreme Court Appears Skeptical Of Merck In Vioxx Case
Nasdaq - Mon Nov 30, 1:47 pm ETWASHINGTON -(Dow Jones)- The U.S. Supreme Court voiced skepticism Monday of Merck & Co. Inc.'s (MRK) arguments that shareholders waited too long to file securities lawsuits alleging the drug maker misrepresented the safety of painkiller drug Vioxx, which it removed from the market in 2004.